| Keywords: |
cancer chemotherapy; survival rate; clinical trial; mortality; laryngectomy; salvage therapy; laryngeal neoplasms; cisplatin; fluorouracil; advanced cancer; patient selection; treatment planning; note; adjuvant therapy; chemotherapy, adjuvant; neoadjuvant therapy; radiotherapy, adjuvant; cancer staging; methodology; antineoplastic agent; controlled clinical trial; multiple cycle treatment; randomized controlled trial; antineoplastic combined chemotherapy protocols; editorial; practice guideline; pathology; head and neck cancer; adjuvant chemotherapy; remission; remission induction; medical practice; organ preservation; larynx cancer; larynx tumor
|
